本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Correvio Pharma Corp.

0.4199
0.0000
成交量:- -
成交额:- -
市值:2,779.38万
市盈率:-0.53
高:0.4199
开:0.4199
低:0.4199
收:0.4199
数据加载中...
2019/12/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/04

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/09/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]